Skip to content
Novaplex™ and Allplex™ Respiratory Panel Assays
Detect and identify 26 respiratory pathogens

Viruses are constantly evolving, between and during seasons. Each year, respiratory infections cause millions of illnesses, hundreds of thousands of hospitalizations, and tens of thousands of deaths.1

Respiratory Panel Assays Available

Order online by selecting the assay of your choice and add to cart. Upon receipt a Seegene Sales representative will follow up to complete your order request.

  • Analytes
    • SARS-CoV-2 (E gene)
    • SARS-CoV-2 (RdRP gene)
    • SARS-CoV-2 (N gene)
  • Analytes
    • Bordetella parapertussis (BPP)
    • Bordetella pertussis (BP)
    • Chlamydophila pneumoniae (CP)
    • Haemophilus influenzae (HI)
    • Legionella pneumophila (LP)
    • Mycoplasma pneumoniae (MP)
    • Streptococcus pneumoniae (SP)
  • Analytes
    • Flu A-H1
    • Flu A-H1pdm09
    • Flu A-H3
    • Influenza A virus (Flu A)
    • Influenza B virus (Flu B)
    • Respiratory syncytial virus A (RSV A)
    • Respiratory syncytial virus B (RSV B)
  • Analytes
    • Adenovirus (AdV)
    • Enterovirus (HEV)
    • Metapneumovirus (MPV)
    • Parainfluenza virus 1 (PIV 1)
    • Parainfluenza virus 2 (PIV 2)
    • Parainfluenza virus 3 (PIV 3)
    • Parainfluenza virus 4 (PIV 4)
  • Analytes
    • Bocavirus 1/2/3/4 (HBoV)
    • Rhinovirus A/B/C (HRV)
    • Coronavirus NL63 (CoV NL63)
    • Coronavirus 229E (CoV 229E)
    • Coronavirus OC43 (CoV OC43)
  • Analytes
    • Human adenovirus (AdV)
    • Human metapneumovirus (MPV)
    • Human parainfluenza virus (PIV)
    • Human respiratory syncytial virus (RSV)
    • Human rhinovirus (HRV)
    • Influenza A virus (Flu A)
    • Influenza B virus (Flu B)
    • SARS-CoV-2 (N gene)
    • SARS-CoV-2 (RdRP gene)
    • SARS-CoV-2 (S gene)
  • Analytes
    • SARS-CoV-2 (RdRP gene)
    • SARS-CoV-2 (N gene)
    • SARS-CoV-2 (S gene)
    • Respiratory syncytial virus A/B (RSV A/B)
    • Influenza A virus (Flu A)
    • Influenza B virus (Flu B)

Nasopharyngeal swab
Nasopharyngeal aspirate
Bronchoalveolar lavage (BAL)
Oropharyngeal (throat) swab
Sputum (Respiratory Panel 4 only)
Cultured cells
Fresh tissue

Compatible instrumentation

Automated Extraction & PCR Setup
Seegene NIMBUS
Seegene STARlet

Real-time PCR

CFX96™ Real-Time PCR Detection System (Bio-Rad)
CFX96™ Dx System (Bio-Rad)
CFX96™ Opus (Bio-Rad)
CFX96 Touch™ Real-Time PCR Detection System (Bio-Rad)

Seegene Viewer Software

  • Quick and easy data analysis and interpretation
  • Interface specialized for multiplex testing
Key Features
  • A single test for the detection of multiple respiratory pathogens 
  • Short TAT (4 hours) from extraction to final results for up to 4 respiratory infection panels in unison 
  • Broad range of respiratory pathogen targets 
  • Informative data with individual Ct reporting for each analyte
Understanding Respiratory Infections

In the United States, influenza, pneumonia, and respiratory syncytial virus (RSV) are projected to infect more than 13 million people annually, with an associated mortality burden of 69,000 to nearly 100,000 deaths attributable to just influenza in the 2017–2018 season alone.2 With the new addition of SARS-CoV-2 the number of respiratory infections will continue to surge, and the US will maintain high infection rates annually. 

Inflammation in various parts of the respiratory tract can be caused by respiratory pathogens, such as viruses and bacteria. Viral infections result from viruses that are inhaled, ingested, or that come into contact with the nasal area and occur through communal transmission. Some viruses such as parainfluenza, RSV, and metapneumovirus can cause lower respiratory infections. Our assays detect the most prevalent respiratory viruses that can be challenging to differentiate between.

Novaplex™ Respiratory Panel Assays* simultaneously detects a broad range of viruses and bacteria from a single test, providing more effective and efficient results. These assays are multiplex real-time PCR assays that detect and identify 16 viruses, 3 Flu subtypes and 7 bacteria in patient’s specimens. Up to 4 panels can be run in unison offering flexible testing options, maximizing throughput while reducing time to result. 

Allplex™ 2019-nCoV Assay (Emergency Use Authorized)** is a multiplex real-time PCR product that can detect 3 target genes of SARS-CoV-2: N gene, RdRP gene, and S gene. While E gene is for the sarbecovirus group that includes both SARS-CoV and SARS-CoV-2.

Novaplex™  SARS-CoV-2/FluA/FluB/RSV Assay* is a multiplex real-time PCR assay designed to detect influenza A, influenza B and respiratory syncytial virus A/B, SARS-CoV-2 N , S , and RdRP gene in a single tube. 

Novaplex™ Respiratory Panel 1A* Multiplex real-time RT-PCR system for detection of Influenza A virus, Influenza B virus, Human respiratory syncytial virus A, Human respiratory syncytial virus B, and subtyping of Influenza A virus (Human Influenza A virus subtype H1, H3, and H1pdm09).

Novaplex™ Respiratory Panel 2* is a multiplex real-time RT-PCR system for detection of Human adenovirus, Human metapneumovirus, Human enterovirus, Human parainfluenza virus 1, Human parainfluenza virus 2, Human parainfluenza virus 3, and Human parainfluenza virus 4.

Novaplex™ Respiratory Panel 3* is a multiplex real-time PCR system for detection of Human bocavirus 1/2/3/4, Human rhinovirus A/B/C, Human coronavirus 229E, Human coronavirus NL63, and Human coronavirus OC43.

Novaplex™ PneumoBacter Assay* is a multiplex real-time PCR system for detection of Chlamydophila pneumoniae, Mycoplasma pneumoniae, Legionella pneumophila, Bordetella pertussis, Bordetella parapertussis, Streptococcus pneumoniae, and Haemophilus influenzae.

Novaplex™ RV Master Assay* is a multiplex real-time RT-PCR assay for the detection of the SARS-CoV-2 E, RdRP, S, N genes, and the S gene variants associated with HV69/70del, Y144del, E48K, E48K, N501Y, P681H.

*Novaplex™ Assays are for Research Use Only. Not for use in diagnostic procedures.

**Allplex™ 2019-nCoV Assay is for Emergency Use Authorization.

Selected Publications

Diagnostic performances of four commercially available assays for the identification of SARS-CoV-2, influenza type A/B virus and RSV.

Three Seegene Allplex™ Assays and a Hologic Aptima™ Assay were evaluated.
Read more

Description of pathogenic bacteria in patients with respiratory symptoms associated with severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) in Colombia

In this study, pathogenic respiratory bacteria were detected using commercial kit Allplex™ Respiratory Panel 4 from nasopharyngeal samples from individuals suffering respiratory symptoms with and without severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Read more

Comparative Evaluation of Allplex Respiratory Panels 1, 2, 3, and BioFire FilmArray Respiratory Panel for the Detection of Respiratory Infections

This study showed concordant performance of the Allplex RP 1, 2, 3, and the BioFire FilmArray RP for the simultaneous detection of multiple respiratory viruses.
Read more

Cepheid Xpert® Flu/RSV and Seegene Allplex™ RP1 show high diagnostic agreement for the detection of influenza A/B and respiratory syncytial viruses in clinical practice

Molecular assays based on reverse transcription-polymerase chain reaction (RT-PCR) provide reliable results for the detection of respiratory pathogens, although diagnostic agreement varies.
Read more
Back To Top